Diagnocure, Inc.
DGCRF · OTC
7/31/2016 | 4/30/2016 | 1/31/2016 | 10/31/2015 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.04 | -0.00 |
| FCF Yield | -92.17% | -48.26% | -5.22% | -4.47% |
| EV / EBITDA | 1.87 | 0.08 | -15.40 | -1.96 |
| Quality | ||||
| ROIC | -54.03% | 942.61% | -42.61% | -21.60% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.62 | -0.08 | 0.67 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | 125.75% | 122.20% | -7.99% | -8.43% |
| Free Cash Flow Growth | 69.60% | -53.35% | -27.77% | 32.39% |
| Safety | ||||
| Net Debt / EBITDA | 2.98 | -0.07 | 1.69 | 0.23 |
| Interest Coverage | 0.00 | 38,601.48 | -1,194.39 | -541.60 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 141.98 | 1.11 | 113.62 | 148.15 |